Elevated Plasma Levels of Tumor Necrosis Factor (TNF)-α, Soluble TNF Receptors, Interleukin (IL)-6, and IL-IO in Patients with Hemorrhagic Fever with Renal Syndrome
Abstract:Plasma levels of cytokines were measured by EIA in 15 subjects hospitalized with nephropathia epidemica, a European form of hantavirus-induced hemorrhagic fever with renal syndrome. Concentrations of tumor necrosis factor (TNF)-alpha and interleukin (IL)-6 were increased in all patients at admission, and the concentration of IL-10 was increased in most. TNF-alpha concentrations were still increased 1 week after onset of disease; levels of IL-6 and IL-10 were normalized. TNF-alpha was undetectable by the WEHI c… Show more
“…Similar elevations of these cytokines are seen following infection with other lentiviruses (Maury & Lahdevirta, 1990 ;Allen et al, 1991 ;Lehmann et al, 1992), as well as non-retroviruses (Torre et al, 1994 ;Linderholm et al, 1996) Systemic levels of TNF-α clearly increase during clinical EIA. The elevated TNF-α levels found in bone marrow from Pre-Tp foals may reflect this increased systemic activity, or it may represent increased activity produced within the local bone marrow environment.…”
Thrombocytopenia is a common finding in infection with equine infectious anaemia virus (EIAV), a lentivirus with some homology to human immunodeficiency virus (HIV). The thrombocytopenia of EIA, like that in some HIV patients, appears to have a multifactorial pathogenesis. To investigate the decreased platelet production seen in experimental EIA, the levels of three potential negative regulators of platelet production -tumour necrosis factor-α (TNF-α), transforming growth factor-β (TGF-β) and interferon-α (IFN-α) -were measured in serum and bone marrow of six severe combined immunodeficient (SCID) foals and ten immunocompetent EIAVinfected foals. Levels of cytokines in pre-infection foal sera and bone marrow were compared with levels observed during clinical EIA. Mean serum levels of TNF-α and IFN-α were significantly higher (P 0n05) on days N 4 to 0 of thrombocytopenia
“…Similar elevations of these cytokines are seen following infection with other lentiviruses (Maury & Lahdevirta, 1990 ;Allen et al, 1991 ;Lehmann et al, 1992), as well as non-retroviruses (Torre et al, 1994 ;Linderholm et al, 1996) Systemic levels of TNF-α clearly increase during clinical EIA. The elevated TNF-α levels found in bone marrow from Pre-Tp foals may reflect this increased systemic activity, or it may represent increased activity produced within the local bone marrow environment.…”
Thrombocytopenia is a common finding in infection with equine infectious anaemia virus (EIAV), a lentivirus with some homology to human immunodeficiency virus (HIV). The thrombocytopenia of EIA, like that in some HIV patients, appears to have a multifactorial pathogenesis. To investigate the decreased platelet production seen in experimental EIA, the levels of three potential negative regulators of platelet production -tumour necrosis factor-α (TNF-α), transforming growth factor-β (TGF-β) and interferon-α (IFN-α) -were measured in serum and bone marrow of six severe combined immunodeficient (SCID) foals and ten immunocompetent EIAVinfected foals. Levels of cytokines in pre-infection foal sera and bone marrow were compared with levels observed during clinical EIA. Mean serum levels of TNF-α and IFN-α were significantly higher (P 0n05) on days N 4 to 0 of thrombocytopenia
“…This is in agreement with the results of Kim et al [25] . It has been reported that increased plasma levels of TNF-α were found in the blood of HFRS patients during the acute phase [28] . The results of Niikura et al [29] confirmed that HTNV infection of endothelial cells might contribute to increased vascular leakage through a prolonged response to TNF-α.…”
Section: Arbidol Is Effective Against Htnv In Vivomentioning
Aim: Arbidol is an immunomodulator that was first developed in Russia. In this study, we report the antiviral activity of arbidol against Hantaan virus (HTNV) in vitro and in vivo. Methods: The antiviral activity of arbidol in vitro was determined by plaque-forming assay, ranging from 0.5 to 8 μg/mL. To investigate whether arbidol has an antiviral effect in vivo, suckling BALB/c mice infected with HTNV were treated with arbidol at 24 h before infection with a 5, 10 or 20 mg·kg -1 ·d -1 , once per day, for 10 days. On day 12 and 28 post infection (pi), histopathological changes and viral antigen were detected. On days 4, 8, 12, and 16 pi, the viral load of target organs and serum TNF-α levels of arbidol-treated animals were determined. Results: Arbidol was found to have potent inhibitory activity against HTNV when added in vitro before or after viral infection, with a 50% inhibitory concentration (IC 50 ) of 0.9 and 1.2 μg/mL, respectively. The 50% lethal dose (LD 50 ) of arbidol for suckling mice was 78.42 mg·kg -1 ·d -1 . Oral administration of arbidol increased both survival rate and mean time to death (MTD). Treatment with arbidol reduced histopathological changes, decreased viral load and viral antigen levels, and modulated the level of serum TNF-α. Conclusion: Arbidol has the ability to elicit protective antiviral activity against HTNV in vivo and in vitro.
“…[11][12][13][14] On the other hand, it has been shown that TNF-␣ decreases the accumulation of viral nucleoproteins in Vero E6 cells infected with Sin Nombre virus. 15 Accordingly, hantavirus nucleocapsid proteins antagonize the signaling pathway of TNF-␣, suggesting that this cytokine may play a role in the immune response against hantavirus.…”
a b s t r a c tWe describe the case of an 18-yr-old male under anti-TNF treatment for Crohn's disease for more than 8 months. He developed fever and biological inflammatory syndrome without absolutely no accompanying sign or symptom or paraclinical abnormality despite extensive work-up performed in the context of his immunocompromised state. Symptoms disappeared after 10 days and a diagnosis of Puumala infection was made retrospectively on a serological basis. The case illustrates that anti-TNF treatment does not worsen the course of Puumala infection and could even be associated with a milder clinical picture.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.